Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck and Samsung BioLogics Expand Strategic Alliance
Thursday, November 02, 2017Merck a leading science and technology company today announced the signing of a Memorandum of Understanding MoU with Samsung BioLogics for a strategic alliance to manufacture biopharmaceutical products and the development of biological processes...
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
Wednesday, November 01, 2017Arcturus Therapeutics Inc a leading RNA medicines company and Synthetic Genomics Inc announced today that they have entered into a research collaboration and worldwide license agreement to develop selfamplifying RNAbased vaccines and therapeutics in...
Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache
Wednesday, November 01, 2017Impel NeuroPharma a Seattlebased privatelyheld biotechnology company focused on therapies for the treatment of central nervous system CNS disorders today announced that the first patient was dosed in the recentlyinitiated Phase clinical trial of INP...
Lannett And Celgene Enter Into Settlement And License Agreement Related To Thalomid®
Tuesday, October 31, 2017Lannett Company Inc announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the US related to Celgenes Thalomid The license agreement permits Lannett to manufactur...
Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim's BI 882370
Tuesday, October 31, 2017Xynomic Pharma a clinical stage US oncology drug development company today announced that it has acquired exclusive global rights to develop manufacture and commercialize BI a ndgeneration RAF inhibitor from Boehringer Ingelheim a top global pharmac...
Zydus receives final approval from the USFDA for Tamoxifen Citrate Tablets USP
Monday, October 30, 2017Zydus Cadila has received the final approval from the USFDA to market Tamoxifen Citrate Tablets USP in the strengths of mg base and mg base The drug is indicated to treat breast cancer in women and men and to reduce the incidence of breast cancer i...
Fosun Pharma to buy France's Tridem for $73 million
Monday, October 30, 2017Shanghai Fosun Pharmaceutical Group Co Ltd said it would buy French drug distributor Tridem Pharma SAS for million euros million in a move to expand its market share in Europe and Africa The Chinese drug maker said in a statement that it will bu...
Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents
Friday, October 27, 2017Evotec AG and TESARO Inc announced a threeyear integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed immunooncology IO target Under the terms of the collaboration Evotec will...
Charles River Announces Expansion of In Vitro Oncology Services
Friday, October 27, 2017Charles River Laboratories International Inc announced its partnership with InSphero AG a leading supplier of D solutions for in vitro drug discovery and development Through this partnership Charles River will license its collection of patientderi...
Incyte and MacroGenics Announce Global Collaboration and Licensing Agreement
Thursday, October 26, 2017Incyte Corporation and MacroGenics Inc announced that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics MGA an investigational monoclonal antibody that inhibits programmed cell death protein PD I...
